(Q38379042)

8 June 2018

title

A Double-Blind, Placebo-Controlled, Pilot Study of Riluzole Monotherapy for Acute Bipolar Depression (English)

1 reference

8 June 2018

1 reference

1 reference

6

1 reference

8 June 2018

Rodrigo Machado-Vieira

object named as

Rodrigo Machado-Vieira

5

0 references

Carlos A Zarate

object named as

Carlos A Zarate

8

1 reference

ORCID Public Data File 2021

author name string

Lawrence T Park

1

1 reference

8 June 2018

Marc S Lener

2

1 reference

8 June 2018

Matthew Hopkins

3

1 reference

8 June 2018

Nicolas Iadorola

4

1 reference

8 June 2018

Allison Nugent

7

1 reference

8 June 2018

language of work or name

English

0 references

publication date

1 June 2017

1 reference

8 June 2018

Journal of Clinical Psychopharmacology

published in

1 reference

8 June 2018

volume

37

1 reference

8 June 2018

issue

3

1 reference

8 June 2018

page(s)

355-358

1 reference

8 June 2018

Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

An excitatory synapse hypothesis of depression

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

Evidence-based treatment strategies for treatment-resistant bipolar depression: a systematic review

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

Novel glutamatergic agents for major depressive disorder and bipolar disorder

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

Glutamatergic modulators: the future of treating mood disorders?

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

Effectiveness of adjunctive antidepressant treatment for bipolar depression

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

Bipolar (spectrum) disorder and mood stabilization: standing at the crossroads?

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

Bipolar depression: phenomenological overview and clinical characteristics

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes).

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

An open-label trial of riluzole in patients with treatment-resistant major depression

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

Bipolar II disorder: symptoms, course, and response to treatment

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

The long-term natural history of the weekly symptomatic status of bipolar I disorder

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5392145

The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1

31 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28338546

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Riluzole inhibits the persistent sodium current in mammalian CNS neurons

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28338546

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/JCP.0000000000000693

1 reference

8 June 2018

PMC publication ID

5392145

1 reference

8 June 2018

PubMed publication ID

28338546

1 reference

8 June 2018